In diabetic nephropathy mice models, Nrf2 knockout attenuates DKD progression through the downregulation of its target genes including angiotensinogen, Sglt2, scavenger receptor CD36, and fatty-acid-binding protein 4 [9]. The gene discussed is AGT; the disease is diabetic kidney disease.